Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Dihydropyridopyrimidines for the treatment of AB-related pathologies

Dihydropyridopyrimidines for the treatment of AB-related pathologies

US Patent 8188101 · Granted May 29, 2012

Estimated economic value: $8,417,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

6-heterocyclyl-4-morpholin-4-ylpyridine-2-one compounds useful for the treatment2024
Aryl-bipyridine amine derivatives as phosphatidylinositol phosphate kinase inhib2024
Pyridinamine-pyridone and pyrimidinamine-pyridone compounds2023
6-aryl-4-morpholin-1-ylpyridone compounds useful for the treatment of cancer and2023
Chromenopyridine derivatives as phosphatidylinositol phosphate kinase inhibitors2023
Morpholinylpyridone compounds2023
Azaindolylpyridone and diazaindolylpyridone compounds2022
Pyridylpyridone compounds2022
Pyridinamine-pyridone and pyrimidinamine- pyridone compounds2021
6-heterocyclyl-4-morpholin-4-ylpyridine-2-one compounds useful for the treatment2021
6-aryl-4-morpholin-1-ylpyridone compounds useful for the treatment of cancer and2021
Compositions and methods for purifying nucleic acids from stabilization reagents2021